NACA Logo |
In
a statement entitled “Re: Nigerian scientist conquers HIV/AIDS”, Director
General of the Agency, Dr. Sani Aliyu, said there was no basis for a claim to
the cure of AIDS as described in the study presented by Ezeibe.
Media
reports had quoted Ezeibe as saying that the drug, produced with “Aluminium
Magnesium Silicate” was tested on 10 persons living with HIV. It was also
reported that a clinical outcome of an ability to “reach all cells” and making
HIV “a conquered organism”.
Aliyu
said: “The claim for a HIV/AIDS cure is not new. It is also not new to find a
scientist using ambiguous scientific methods and practices to buttress this
claim, and to find obscure journals increasingly prepared to publish these
claims.”
Examining
the facts, the NACA DG who said the study quoted by Ezeibe did not follow
standard ethical protocols for clinical trials, also noted that there was no
evidence from the publication that the authors obtained ethical clearance from
an appropriate body in Nigeria to conduct this study, and only ambiguous
evidence that informed consent was sought from the evidently vulnerable
patients.
“We
are concerned that the publicity given to these claims will stop patients with
HIV from taking life-saving anti-retrovirals and give them false hope of a cure.
It will be a great disservice to this vulnerable group of patients for the
media to disseminate these claims in the absence of sound scientific evidence.
“There
are long established, tried and tested routes for the discovery, development
and validation of modern medicines before they can be registered and used for
treatment in humans and animals.”
He
urged all academics to follow legal and scientifically acceptable methods in
conducting their research and to avoid making premature claims that are capable
of derailing the huge progress made in the last two decades on the war against
HIV/AIDS.
Aliyu
also urged media houses in Nigeria to seek comments from the leadership of the
relevant government parastatals and professional bodies when it receives new
research findings related to our areas of responsibility.
“We call on all patients living with HIV that are currently taking their medications to continue to do so and to see their doctors if they have any concern. The NACA helpline (6222) is available on working days from 8am-8pm for members of the public seeking more information on HIV disease,” he affirmed.
No comments:
Post a Comment